CITIGROUP INC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 48 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$6
-14.3%
80.0%0.00%
Q4 2022$7
-100.0%
8
-99.9%
0.00%
Q3 2022$40,000
+37.9%
6,585
-6.9%
0.00%
Q2 2022$29,0007,073
+707200.0%
0.00%
Q2 2021$0
-100.0%
1
-99.8%
0.00%
Q1 2021$4,000
-50.0%
610
-65.5%
0.00%
Q4 2020$8,000
+300.0%
1,770
+300.5%
0.00%
Q3 2020$2,000
-94.4%
442
-64.5%
0.00%
Q2 2020$36,000
+33.3%
1,246
-1.0%
0.00%
Q1 2020$27,000
+50.0%
1,258
+41.7%
0.00%
Q4 2019$18,0008880.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,118,761$14,533,0003.83%
Ghost Tree Capital, LLC 904,225$4,214,0001.23%
RA Capital Management 5,914,252$27,560,0000.38%
Vivo Capital, LLC 1,232,394$5,743,0000.26%
Nan Fung Group Holdings Ltd 142,900$666,0000.21%
Ikarian Capital, LLC 629,384$2,934,0000.21%
NEA Management Company, LLC 3,142,958$14,646,0000.17%
SAMLYN CAPITAL, LLC 1,716,067$7,998,0000.11%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,788,0000.09%
GSA CAPITAL PARTNERS LLP 90,665$422,0000.04%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders